• OPEN AN ACCOUNT
Indian Indices
Sensex
75,993.91 -521.52
( -0.68%)
Global Indices
Nasdaq
53,423.66 -283.45
(-0.53%)
Dow Jones
7,737.34 -31.37
(-0.40%)
Hang Seng
66,225.50 1,204.56
(1.85%)
Nikkei 225
10,828.70 -2.82
(-0.03%)
Forex
USD-INR
94.48 -0.24
(-0.26%)
EUR-INR
109.71 0.00
(0.00%)
GBP-INR
127.63 -0.19
(-0.15%)
JPY-INR
0.60 0.01
(1.60%)

EQUITY - MARKET SCREENER

Acutaas Chemicals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
543349
INE00FF01025
203.7821787
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ACUTAAS
65.23
25922.85
EPS(TTM)
Face Value()
Div & Yield %
48.54
5
0.08
 

emco ltd
ICICI Bank’s board OKs $5 billion overseas borrowing limit
Aug 21,2026
The revised limit is double the earlier limit of $2.50 billion approved by the bank’s board on 18 July 2026 for borrowings through bonds, notes and offshore certificates of deposits in overseas markets.

The borrowing programme is aimed at providing the bank with additional flexibility to raise funds from international markets, subject to prevailing regulatory requirements and market conditions.

ICICI Bank is the second-largest private sector bank in India, offering a diversified portfolio of financial products and services to retail, SME and corporate customers. The bank has an extensive network of branches, ATMs and other touch-points.

The bank’s standalone net profit rose 15.95% to Rs 14,804.50 crore in Q1 FY27 as against Rs 12,768.21 crore posted in Q1 FY26. Total income increased 5.43% year on year (YoY) to Rs 54,246.84 crore in Q1 FY27.

The counter rose 0.47% to Rs 1,418.15 on the BSE.